BNGO vs MCO · rev $14.9M vs P/E 33, rev $4.26B
Bionano Genomics Inc (BNGO) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
BNGO currently screens at market cap $13.4M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the BNGO and MCO stock pages for the full models.
Not investment advice.